8 completed, 4 unknown, 2 recruiting, 1 terminated. 15 Phase 2, 3 Phase 3, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 15 | Completed 8, Unknown 4, Recruiting 2, Terminated 1 |
| Phase 3 | 3 | Completed 1, Recruiting 1, Terminated 1 |
| Phase 1 | 2 | Completed 1, Unknown 1 |
Follow Hemorrhagic Stroke: new trials by email Literature Review of Hemorrhagic Stroke trials Research Report on Hemorrhagic Stroke
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Minocycline in Stroke Study at Maimonides Minocycline 200mg - Stroke, Ischemia Stroke | Phase 2 / Phase 3 | Recruiting | Joyce Chen | 1164 | 2026-02-02 | 2026-03-19 |
| Maimonides Minocycline in Stroke Study Minocycline - Stroke, Acute, Ischemic Stroke | Phase 2 / Phase 3 | Terminated | Maimonides Medical Center | 2 | 2023-11-01 | 2025-12-17 |
| Fitness After Stroke Trial Exercise MICT, Exercise HIIT - Stroke, Stroke, Ischemic | Phase 2 | Completed | University of Kansas Medical Center | 59 | 2023-07-03 | 2026-01-06 |
| PROpranolol for Cerebral Hemorrhage-ASsociated pnEumonia (PRO-CHASE) Propranolol Hydrochloride, control group - Stroke, Vascular Accident | Phase 2 / Phase 3 | Completed | Beijing Tiantan Hospital | 168 | 2023-02-21 | 2025-07-14 |
| Promoting Recovery After STroke With Amantadine Amantadine, Placebo - Stroke, Ischemic, Stroke Hemorrhagic | Phase 2 | Recruiting | University of Pennsylvania | 60 | 2022-02-01 | 2026-03-30 |
| Poststroke Depression in Hemorrhagic Stroke Fluoxetine, Placebo - Stroke Hemorrhagic, Depression | Phase 2 | Completed | University of Washington | 8 | 2019-03-01 | 2025-08-06 |
| Efficacy, Safety and Tolerability of BAF312 Compared to Placebo in Patients With Intracerebral Hemorrhage (ICH). BAF312 solution, Matching Placebo for BAF312 solution, BAF312 tablet - Hemorrhagic Stroke, Intracerebral Hemorrhage (ICH) | Phase 2 | Completed | Novartis Pharmaceuticals | 32 | 2017-12-24 | 2022-08-12 |
| A Pilot Study of Minocycline in Intracerebral Hemorrhage Patients Minocycline - Intracerebral Hemorrhage | Phase 1 / Phase 2 | Completed | Augusta University | 16 | 2013-02-01 | 2018-04-26 |
| Prehospital COOLing 1 (PreCOOL 1) Cold crystalloid infusions, 0.9%NaCl or Ringer's solution - Stroke | Phase 2 | Unknown | University Hospital Heidelberg | 40 | 2012-09-01 | 2013-06-24 |
| A Randomized Trial Comparing 2 Methods for Rapid Induction of Cooling in Stroke Patients, Cold Infusions vs. EMCOOLS Brain.Pad (iCOOL 3) Cold crystalloid infusions, 0.9%NaCl or Ringer's, EMCOOLS Brain.Pad - Ischemic Stroke, Hemorrhagic Stroke | Phase 2 | Completed | University Hospital Heidelberg | 20 | 2012-01-01 | 2012-08-15 |
| A Randomized Trial Comparing 2 Methods for Rapid Induction of Cooling in Stroke Patients, Cold Infusions vs. EMCOOLS Flex.Pads (iCOOL 2) Cold crystalloid infusions, 0.9%NaCl or Ringer's solution, EMCOOLS Flex.Pads - Ischemic Stroke, Hemorrhagic Stroke | Phase 2 | Unknown | University Hospital Heidelberg | 20 | 2012-01-01 | 2013-06-24 |
| Establishment of Clinical Basis for Hematopoietic Growth Factors Therapy in Brain Injury Combination injection of EPO and G-CSF, Injection of normal saline - Neurological Diseases, Ischemic Stroke | Phase 1 / Phase 2 | Unknown | Yonsei University | 60 | 2011-07-05 | 2020-12-28 |
| A Randomized Trial Comparing 2 Methods for Rapid Induction of Cooling in Stroke Patients, Cold Infusions vs. RhinoChill (iCOOL 1) RhinoChill, Cold crystalloid infusions, 0.9%NaCl or Ringer's solution - Ischemic Stroke, Hemorrhagic Stroke | Phase 2 | Completed | University Hospital Heidelberg | 20 | 2010-09-01 | 2012-04-26 |
| Study of the Pathogenesis and Molecular Mechanism of "YURE" in Internal Intractable Diseases Chinese herbs formula, Mannitol - Stroke | Phase 2 | Unknown | Nanjing University of Traditional Chinese Medicine | 300 | 2007-11-01 | 2009-07-08 |
| Cerebril™ in Patients With Lobar Hemorrhage Related to Cerebral Amyloid Angiopathy NC-758 (Anti amyloidotic [Aß] agent) - Stroke, Neurologic Diseases, General | Phase 2 | Completed | Bellus Health Inc. - a GSK company | 30 | 2003-02-01 | 2005-06-24 |
Stroke (13) · Ischemic Stroke (9) · Cerebral Hemorrhage (4) · Hypothermia (4) · Intracranial Hemorrhages (4) · Cerebrovascular Disorders (3) · cyclopia sequence (3) · Cerebral Amyloid Angiopathy (1) · Cerebral Palsy (1) · Depression (1) · Emergencies (1) · Hemorrhage (1) · Infections (1) · Motor Activity (1)
Brain Diseases (15) · Cardiovascular Diseases (15) · Central Nervous System Diseases (15) · Vascular Diseases (15) · Nervous System Diseases (14) · Cerebrovascular Disorders (12) · Pathologic Processes (9) · Pathological Conditions, Signs and Symptoms (9) · Hemorrhage (7) · Body Temperature Changes (4) · Intracranial Hemorrhages (4) · Signs and Symptoms (4) · Behavior (2) · Stroke (2) · Amyloidosis (1)
Sodium Chloride (4) · Minocycline (3) · Ringer's Solution (3) · Amantadine (1) · Control Groups (1) · Exercise (1) · Fluoxetine (1) · Granulocyte Colony-Stimulating Factor (1) · Mannitol (1) · NC 758 (1) · Pharmaceutical Preparations (1) · Propranolol (1) · siponimod (1)
University Hospital Heidelberg (4) · Augusta University (1) · Beijing Tiantan Hospital (1) · Bellus Health Inc. - a GSK company (1) · Joyce Chen (1) · Maimonides Medical Center (1) · Nanjing University of Traditional Chinese Medicine (1) · Novartis Pharmaceuticals (1) · University of Kansas Medical Center (1) · University of Pennsylvania (1) · University of Washington (1) · Yonsei University (1)
United States (8) · Germany (4) · China (2) · South Korea (1)
Sven Poli, Dr. med. (4) · Erik Popp, PD Dr. med. (1) · Jeffrey A Switzer, DO (1) · Kevin N. Sheth, MD (1) · Mianhua Wu, Dr. (1) · Michael Levitt, MD (1) · Qingliang T. Wang, MD, PhD (1) · Sandra A Billinger, PhD (1) · Steven M. Greenberg, M.D., PhD. (1)
PMID 25346332, PMID 28887388, PMID 41510301, PMID 41891032, PMID 42239661